17 Diagnostics & Research Stocks Moving In Tuesday's Session

Gainers

Soleno Therapeutics, Inc. SLNO stock increased by 15.1% to $3.28 during Tuesday's regular session. The most recent rating by Craig-Hallum, on January 10, is at Buy, with a price target of $8.00.

DermTech, Inc. DMTK stock moved upwards by 9.6% to $12.50.

Trinity Biotech, Inc. TRIB stock increased by 9.3% to $1.14.

Anixa Biosciences, Inc. ANIX shares surged 7.1% to $3.76. The most recent rating by B. Riley, on December 30, is at Buy, with a price target of $8.00.

Genetic Technologies, Inc. GENE shares moved upwards by 6.1% to $4.18.

T2 Biosystems, Inc. TTOO stock rose 4.3% to $1.22. According to the most recent rating by Janney Capital, on November 26, the current rating is at Neutral.

Check-Cap, Inc. CHEK shares moved upwards by 4.0% to $2.13.

Co-Diagnostics, Inc. CODX shares surged 3.7% to $1.13.

Bioanalytical Systems, Inc. BASI shares surged 3.5% to $6.25.

Precipio, Inc. PRPO shares increased by 3.4% to $2.17. The most recent rating by Maxim Group, on November 22, is at Buy, with a price target of $4.00.

Oxford Immunotec Global, Inc. OXFD stock surged 3.0% to $16.64.

 

Losers

Organovo Holdings, Inc. ONVO shares plummeted 14.3% to $0.39 during Tuesday's regular session.

OpGen, Inc. OPGN stock fell 9.4% to $1.73.

CareDx, Inc. CDNA stock decreased by 5.4% to $22.33.

Psychemedics, Inc. PMD shares decreased by 4.3% to $10.16.

Invitae, Inc. NVTA stock declined 4.1% to $18.82.

BioTelemetry, Inc. BEAT shares plummeted 3.1% to $52.45. The most recent rating by SunTrust Robinson Humphrey, on January 08, is at Buy, with a price target of $58.00.

Posted In: Intraday UpdateMarketsMoversTrading IdeasDiagnostics & Research StocksTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...